Related Experiment Video
Updated: Jul 3, 2026
11:34
A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Novel hepatitis C drugs in current trials
Bernd Kronenberger1, Christoph Welsch, Nicole Forestier
1Zentrum der Inneren Medizin, Medizinische Klinik 1, Klinikum der Johann Wolfgang Goethe-Universität, Frankfurt, Germany.
Clinics in Liver Disease
|July 16, 2008
Summary
New hepatitis C treatments show promise for patients resistant to standard therapy. Research into specifically targeted antiviral therapies for hepatitis C (STAT-C) aims to improve cure rates and potentially replace interferon-alfa.
Area of Science:
- Hepatology
- Virology
- Pharmacology
Background:
- Chronic hepatitis C affects many patients, with nearly half not responding to current standard treatments.
- Limitations in existing therapies necessitate the development of novel treatment strategies.
Purpose of the Study:
- To explore the development and potential of specifically targeted antiviral therapies for hepatitis C (STAT-C).
- To review advancements enabling new antiviral drug discovery for hepatitis C.
Main Methods:
- Advancements in HCV protein structure determination.
- Development of subgenomic replicon systems for HCV research.
- Establishment of infectious HCV cell culture clones.
Main Results:
- Multiple classes of HCV-specific antiviral compounds are in preclinical and clinical development.
- These agents offer the potential for combination therapies.
Conclusions:
- Antiviral combinations may enhance treatment effectiveness and shorten therapy duration.
- Future treatments might eliminate the need for interferon-alfa in hepatitis C management.
Related Concept Videos
01:25Hepatitis
Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
01:28Viral Hepatitis I: Introduction
Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...
01:22Antiviral Nucleoside Inhibitors
Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...
01:30Inhibitors of Viral Protein Synthesis
Protein synthesis is indispensable for viral replication, as viruses lack the cellular machinery required for this process and must hijack the host's translational apparatus. In response, host cells deploy a critical innate immune defense involving interferons, specialized cytokines that play a central role in inhibiting viral propagation.Upon viral detection, infected cells release interferons that bind to receptors on adjacent uninfected cells, activating the JAK-STAT signaling pathway and...
01:25Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...